Starpharma Holdings Ltd and Gowan Company LLC announced a new partnership using Starpharma’s Priostar dendrimer technology in crop protection formulations.
Under the agreement, Australia’s Starpharma’s Priostar dendrimers will be evaluated as potential enhancements for certain Gowan products intended for high value markets.
The partnership with Gowan, a US-based company with global agrochemical sales of more than $300 million, aims to broaden crop protection offerings and open new markets through the use of Starpharma’s Priostar dendrimer technology.
“We are excited at the prospect of working with Gowan to develop new formulation options,” said Starpharma Chief Executive Officer Dr. Jackie Fairley. “Gowan’s focus on providing tailored solutions to farmers’ problems fits well with our technology’s capabilities.”
“At Gowan we are proud of our history of providing a complete offering to farmers and we are very pleased to be able to include Starpharma’s innovative technology for potential improvements to our crop protection formulations,” said Sandra Alcaraz, disruptive technologies manager.
“With a strong product portfolio and international distribution network, we are able to effectively apply innovative technologies in crop protection products for our key markets.”
Starpharma 表示，其 Priostar 树枝状聚合物通过以下方式使农化公司和最终用户种植者受益：
• 提高产品功效；
• 更浓缩的配方可降低供应链成本并更易于处理；
• 减少溶剂负荷；和
• 通过增加粘附力提高生物利用度，减少雨水流失造成的损失，以及多次应用的需要。